Landmark Cardiology Trial

Contact: Amanda White Nelson

Photo of David Moliterno
David Moliterno


LEXINGTON, Ky. (Aug. 13, 2004) -- Dr. David Moliterno, professor of internal medicine and chief of cardiovascular medicine, University of Kentucky College of Medicine, will serve as national principal investigator for a major U.S. multi-center trial for high risk coronary patients.

Guilford Pharmaceuticals announced two landmark trials that will advance the field of interventional cardiology by attempting to determine the optimal therapeutic regimen for high-risk patients undergoing percutaneous coronary intervention (PCI). Moliterno, an interventional cardiologist, is also co-director of UK’s Gill Heart Institute.

(For more information, see news release from Guilford Pharmaceuticals).

Back to Campus News Homepage